Cash Equivalent

 
News Articles for Cash Equivalent top ^
Despite an estimated $8-$10 million negative revenue impact from severe weather and Medicare reimbursement cuts, Adjusted EBITDA (1) increased 8.2%, from $25.6 million in the first quarter of 2013 to $27.7 in the first quarter of 2014 Implementation from the previously announced $30 million cost savings initiatives enhanced operating margins Same-center revenue from centers not impacted by the east coast extreme weather conditions increased 4.2% from last year's first quarter Procedural volumes are benefitting from the over 8 million enrollees in state and privately managed health insurance exchanges, including over 1.4 million enrollees in California Completed the refinancing of its junior debt capital during the quarter, yielding over $5 million of annual interest cost savings, increasing financial flexibility and extending maturities Ignoring the loss from debt extinguishment associated with the refinancing, RadNet narrowed its net loss by
Sign-up for RadNet Reports First Quarter Financial Results and Adjusts Upwards Several 2014 Guidance Ranges investment picks
2014/5/8
Live Conference Call and Webcast Scheduled at 11 a.m. ET Friday, May 9 at : http://www.media-server.com/m/p/povwyz6o MCLEAN, Va., May 8, 2014 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq:LTBR) , a leading innovator of nuclear fuel designs and provider of nuclear energy consulting services, today provided a business update on the progress of its nuclear fuel technology and consulting operations and reported financial results for the quarter ended March 31, 2014.
Sign-up for Lightbridge Announces 2014 First Quarter Business Update and Financial Results investment picks
LEVITTOWN, Pa., May 8, 2014 (GLOBE NEWSWIRE) -- StoneMor Partners L.P. (NYSE:STON) ("StoneMor") announced its results from operations for the three months ended March 31, 2014.
Sign-up for StoneMor Partners L.P. Announces First Quarter 2014 Financial Results investment picks
HOUSTON, May 8, 2014 (GLOBE NEWSWIRE) -- EPL Oil & Gas, Inc. (EPL or the Company) (NYSE:EPL) today reported financial and operational results for the first quarter of 2014.
Sign-up for EPL Announces Results for the First Quarter of 2014 investment picks
Company Reports Q1 2014 Consolidated Revenues of $189.9 million DOWNERS GROVE, Ill., May 7, 2014 (GLOBE NEWSWIRE) -- FTD Companies, Inc. (Nasdaq:FTD) ("FTD" or the "Company"), a premier floral and gifting company, today announced financial results for the first quarter ended March 31, 2014.
Sign-up for FTD Companies, Inc. Reports First Quarter 2014 Financial Results investment picks
NORCROSS, Ga., May 13, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT) , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the quarter ended March 31, 2014.
Sign-up for Galectin Therapeutics Reports First Quarter 2014 Financial Results investment picks
SOLANA BEACH, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK) , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the first quarter ended March 31, 2014.
Sign-up for Evoke Pharma Reports First Quarter 2014 Results investment picks
DECLARES CASH DIVIDEND OF $0.05 PER SHARE FOR THE FIRST QUARTER ATHENS, Greece, May 13, 2014 (GLOBE NEWSWIRE) -- Diana Containerships Inc. (Nasdaq:DCIX) , (the "Company"), a global shipping company specializing in the ownership of containerships, today reported net income of $0.3 million for the first quarter of 2014, compared to a net loss of $31.8 million for the respective period of 2013.
Sign-up for Diana Containerships Inc. Reports Financial Results for the First Quarter Ended March 31, 2014 investment picks
NEW YORK, May 13, 2014 (GLOBE NEWSWIRE) -- Liquid Holdings Group, Inc. (Nasdaq:LIQD) ("Liquid" or the "Company"), a provider of a single platform that integrates order, execution, and risk management as well as reporting and shadow NAV in the cloud for the financial services community, today reported results for the first quarter ended March 31, 2014.
Sign-up for Liquid Holdings Group Reports First Quarter 2014 Results investment picks
-Q1 Revenue Increase d 174.0% YoY to $40.2 Million- JINHUA, China, May 12, 2014 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (the "Company" or "Kandi") (Nasdaq:KNDI) , today reported its financial results for the first quarter ended March 31, 2014.
Sign-up for Kandi Technologies Reports First Quarter 2014 Financial Results and Revenue for EV Sales More Than Tripled investment picks
THE WOODLANDS, Texas, May 12, 2014 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced financial results for the first quarter ended March 31, 2014.
Sign-up for Repros Therapeutics Inc.(R) Reports First Quarter 2014 Financial Results investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Achaogen Announces First Quarter 2014 Results investment picks
BEIJING, May 15, 2014 (GLOBE NEWSWIRE) -- Andatee China Marine Fuel Services Corporation (Nasdaq:AMCF) , a leading independent operator engaged in the production, storage, distribution, trading of blended marine fuel oil for cargo and fishing vessels in China, today announced its financial results for the first quarter of 2014 ended March 31, 2014.
Sign-up for Andatee China Marine Fuel Services Corporation Reports First Quarter 2014 Financial Results investment picks
Signs Collaboration Agreement With Janssen Biotech; Initiates Phase II Clinical Study of CAP-1002 LOS ANGELES, May 15, 2014 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (OTCBB:CAPR) , a biotechnology company focused on developing novel therapeutics to prevent and treat diseases, with a primary focus on heart disease, today provided a business and financial update for the first quarter ended March 31, 2014.
Sign-up for Capricor Therapeutics Reports First Quarter 2014 Business Highlights investment picks
Pompano Beach, Fla., May 15, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ: DSKX) , a leading developer of personal care products and specialty pharmaceuticals, today announced financial results for the three months ended March 31, 2014.
Sign-up for DS Healthcare Group Reports First Quarter 2014 Financial Results investment picks
TEL AVIV, Israel, May 15, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd.
Sign-up for Alcobra Announces First Quarter Financial Results and Corporate Update investment picks
VANCOUVER, British Columbia, May 14, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced its financial and operating results for the first quarter ended March 31, 2014 and provided a corporate update.
Sign-up for Tekmira Provides Corporate Update and Announces First Quarter 2014 Results investment picks
Luverne plant commences Side-by-Side production ENGLEWOOD, Colo., May 14, 2014 (GLOBE NEWSWIRE) -- Gevo, Inc. (Nasdaq:GEVO) today announced its financial results for the three months ended March 31, 2014 and provided an update on recent corporate highlights.
Sign-up for Gevo Reports First Quarter 2014 Financial Results investment picks
IRVINE, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHROD), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced its financial results for the fiscal quarter ended March 31, 2014 and provided a corporate update on operations and progress on lead candidate AHRO-001.
Sign-up for AtheroNova Announces Q1 2014 Financial Results/Highlights investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Cash Equivalent
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Cash Equity Fund  |  Next: Cash ETF